Patients who are currently receiving another investigational drug are not eligible
253.0
Patients who are currently receiving another investigational drug are not eligible
77.0
Patients who are currently receiving another investigational drug are not eligible
154.0
Patients who are currently receiving another investigational drug are not eligible
148.0
Patients who are currently receiving another investigational drug are not eligible
484.0
Patients who are receiving any other anti-cancer or investigational drug therapy are ineligible
110.0
Patients who are currently receiving another investigational drug are not eligible
67.0
Patients who are currently receiving another investigational drug
56.0
Investigational drugs: Patients who are currently receiving another investigational drug are not eligible
65.0
Patients who are currently receiving another investigational drug are not eligible
36.0
Patients who are receiving any other anticancer or investigational drug therapy are not eligible
25.0
Patients who are currently receiving another investigational drug are not eligible
146.0
Patients who are currently receiving another investigational drug are not eligible
51.0
Patients who are currently receiving another investigational drug
53.0
Patients who are currently receiving another investigational drug are not eligible
49.0
Patients who are currently receiving another investigational drug are not eligible
49.0
